Specifications
Applications
Application Notes
Reference Antibody
Each laboratory should determine an optimum working titer for use in its particular application.
Other applications have not been tested but use in such assays should not necessarily be excluded.
Target
Alternative Names
Codrituzumab-MMAE; GPC3; glypican 3; glypican proteoglycan 3; Glypican-3; GTR2-2; GTR22
Citations
Have you cited DMAB-CLS25216 in a publication?
Let us know and earn a reward for your research.
| Product Name |
Cat. No. |
Applications |
Host Species |
Datasheet |
Price |
Add to Basket |
| Product Name |
Cat. No. |
Applications |
Host Species |
Datasheet |
Price |
Add to Basket |
Wang, HL; Anatelli, F; et al. Glypican-3 as a Useful Diagnostic Marker That Distinguishes Hepatocellular Carcinoma From Benign Hepatocellular Mass Lesions. ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE 132:1723-1728(2008).
Gao, W; Kim, H; et al. Inactivation of Wnt Signaling by a Human Antibody That Recognizes the Heparan Sulfate Chains of Glypican-3 for Liver Cancer Therapy. HEPATOLOGY 60:576-587(2014).
COA
Certificate of Analysis
